Faricimab for previously-treated eyes with neovascular age-related macular degeneration with inadequate response - 6-month interim analysis of the FURGGHORN study. - Phan LT; Chin J; Broadhead GK; Hong TH; Mehta H; Chang JH; Fraser-Bell S; Cheung CMG; Sun CZ; Luckie AP; Wickremasinghe SS; Liew G; et al. (Asia-Pacific journal of ophthalmology (Philadelphia, Pa.), 2026)